Given the higher risk of PDAC in PJS and similar mutations in IPMNs and pancreatic cancer, STK11/LKB1 mutations noted in IPMNs among PJS patients may predispose this patient population to higher rates of progression to PDAC versus the general population. Here, STK11 is linked to Peutz-Jeghers syndrome.